Cite
HARVARD Citation
Jambor, I. et al. (2016). Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Acta oncologica. pp. 59-67. [Online].